<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859626</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1112</article-id><article-id pub-id-type="other">EPV0400</article-id><article-id pub-id-type="pii">S092493382401112X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Antidepressants and suicide risk in children and adolescents</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Riam</surname><given-names>S.</given-names></name><xref rid="aff2507" ref-type="aff"/><xref rid="cor0968" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Baabouchi</surname><given-names>N.</given-names></name><xref rid="aff2507" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>kisra</surname><given-names>H.</given-names></name><xref rid="aff2507" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>laajili</surname><given-names>F.</given-names></name><xref rid="aff2507" ref-type="aff"/></contrib></contrib-group><aff id="aff2507"><institution>Arrazi University Psychiatric Hospital</institution>, Rabat Faculty of Medicine and Pharmacy Mohammed V University, <city>RABAT</city>, <country>Morocco</country></aff><author-notes><corresp id="cor0968"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1087">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S536</fpage><lpage>S536</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382401112Xa.pdf"/><abstract><sec id="sec5820"><title>Introduction</title><p>In recent years, the prescription of antidepressants for children has faced significant scrutiny due to studies suggesting an elevated risk of suicide among those treated with these medications. The primary objective of this study is to examine the causal connection between antidepressant use and suicidal behavior in children and adolescents.</p></sec><sec id="sec5821"><title>Objectives</title><p>In this article, we will examine the current research on this topic and discuss the current status of practical guidelines and recommendations for prescribing antidepressants to children and adolescents.</p></sec><sec id="sec5822"><title>Methods</title><p>We conducted a literature review using the Google Scholar database, employing keywords such as antidepressants, suicide, children, and adolescents.</p></sec><sec id="sec5823"><title>Results</title><p>The literature yielded conflicting data. While it has been established that SSRIs moderately elevate the risk of suicide ideation and attempts, with venlafaxine, paroxetine, and sertraline showing a higher risk compared to other SSRIs like fluoxetine and citalopram, several studies indicate that their use is linked to a noteworthy reduction in suicide rates among children and adolescents.</p></sec><sec id="sec5824"><title>Conclusions</title><p>The existence of a definitive causal relationship between antidepressants and suicidality in children and adolescents is currently uncertain, and the underlying mechanisms remain inadequately understood.</p></sec><sec id="sec5825"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>